The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.
Global Clinical Trial Supplies Market Report By Clinical Phase (Phase I, Phase II, Phase III, Other), By Service (Manufacturing, Packaging, Labeling, and Blinding, Comparator Sourcing, Logistics, Distribution, Storage, and Retention, Solutions), By Therapeutic Area (Oncology, Neurological and Mental Disorders, Infectious and Immune System Diseases, Digestive System Diseases, Blood Disorders, Other Therapeutic Areas) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028
ID:VMR11214170
April 2021
Report Formats: Electronic (PDF), MS EXCEL
Global Clinical Trial Supplies Market Overview
The key driver impacting the clinical trial supplies market is the rising number of patients suffering from chronic diseases such as cancer, epilepsy, and HIV. For instance, According to WHO report estimations, globally, cancer is the second most leading cause of death. There are one in six deaths that take place due to cancer. It accounts for 9.6 million deaths in 2018. As per the UNAIDS organization 2020 report, Globally, around 38.0 million people were living with HIV in 2019. Since the coronavirus epidemic (end 2019), around 75.7 million people have become infected by HIV. Moreover, increasing complexities, and rising number of biologics and biosimilar drugs in trials is estimated to be an important factor that positively impacts market growth.
The increasing number of life sciences research in various countries and rising government funding to develop new drugs worldwide is estimated to augment clinical trial supplies demand in the forecast period. For instance, NIH funding contributes to published research connected with every one of the 210 new drugs permitted by the Food and Drug Administration between 2010–2016. collectively, grant funding totaling more than $100 billion for this research. as per the U.K. Bioindustry Association, U.K. being a global leader in life sciences, the UK sector, had invested £4.3 billion in 2017. the industry continually invests more in research & development than any other in the UK. It is committed to raising investment in R&D from 1.69% of GDP in 2017 to 2.4% by 2027. however, the shortage of trained professionals may hamper the global clinical trial supplies market in the long run. also, lack of infrastructure negatively impacts market growth. the current industry trends, such as a surge in focus on determining toxicity level in the early stages of drug discovery, globalization, and rise in the number of clinical trials, are expected to provide market players with new market opportunities.
The clinical trial supplies market is vast, with many local and global players. the key leaders follow different strategies to augment their market position, such as mergers, contracts, extending product portfolio, expansions, acquisitions, and product innovations to enhance their market share at the global level. The known players included in the report are PAREXEL International Corporation, KLIFO A/S, Movianto GmbH, Biocair International Ltd., Almac Group Ltd, Patheon Inc., Thermo Fischer Scientific, PCI Services, Sharp Packaging Services, and Catalent Pharma Solutions.
In this research report, the clinical trial supplies market is segmented by phase, services, therapeutic area, and region.
Analysis by Phases:
By Phases, the report is categorized into phase I, phase II, phase III, phase IV, and BA/BE studies. Phase III dominates the phases segment with over 20% share in 2020. Phase III trials are the most costly, time-consuming, and difficult to design and run. Moreover, it necessitates thousands of people to execute experiments. These experiments go for a more extended period, requiring more supplies and services in several pharma companies and contract research organizations (CROs), thus contributing to the high demand for clinical trial supplies in the forecast period.
Analysis by Services:
By services, the report is categorized into manufacturing, packaging, labeling, and blinding, comparator sourcing, logistics, distribution, storage, and retention, and solutions. Logistics services dominate the product segment with over 60% share in 2020. It is due to the globalization of clinical trials and the increasing number of clinical trials involving temperature-sensitive products. Moreover, growing awareness regarding the importance of clinical trial logistics and end-to-end solutions for respecting the desired study timelines contributes to the growth of the logistics segment in the forecast period.
Analysis by Therapeutic Area:
By therapeutic area, the report is categorized oncology, neurological and mental disorders, infectious and immune system diseases, digestive system diseases, blood disorders, and other therapeutic areas. Oncology areas are estimated to show considerable growth in the forecast period. It is due to the increasing demand for technologically advanced cell-based therapies. Moreover, the adoption of advanced instruments and consumables in pharmaceutical and biotechnology companies for cancer research and experiments drives the demand from the oncology segment in the forecast period.
Analysis by Region:
In the regional outlook of the global clinical trial supplies market, the North America region dominates with a market share of 30% in 2020. It is due to the presence of well-established CROs and the growing investments in R&D by pharmaceutical and biopharmaceutical in the U.S. that are driving the North America region. Moreover, the increasing occurrence of chronic diseases and rise in the number of life sciences researches contribute to the high growth of the clinical trial supplies market across North America.
Market Segmentation covered in the Report:
By Clinical Phase
The key driver impacting the clinical trial supplies market is the rising number of patients suffering from chronic diseases such as cancer, epilepsy, and HIV. For instance, According to WHO report estimations, globally, cancer is the second most leading cause of death. There are one in six deaths that take place due to cancer. It accounts for 9.6 million deaths in 2018. As per the UNAIDS organization 2020 report, Globally, around 38.0 million people were living with HIV in 2019. Since the coronavirus epidemic (end 2019), around 75.7 million people have become infected by HIV. Moreover, increasing complexities, and rising number of biologics and biosimilar drugs in trials is estimated to be an important factor that positively impacts market growth.
According to Value Market Research, the global clinical trial supplies market size was valued at around USD 1700 million in 2020 and is estimated to grow at a CAGR of about 10% during the forecast period of 2021 to 2027.
The increasing number of life sciences research in various countries and rising government funding to develop new drugs worldwide is estimated to augment clinical trial supplies demand in the forecast period. For instance, NIH funding contributes to published research connected with every one of the 210 new drugs permitted by the Food and Drug Administration between 2010–2016. collectively, grant funding totaling more than $100 billion for this research. as per the U.K. Bioindustry Association, U.K. being a global leader in life sciences, the UK sector, had invested £4.3 billion in 2017. the industry continually invests more in research & development than any other in the UK. It is committed to raising investment in R&D from 1.69% of GDP in 2017 to 2.4% by 2027. however, the shortage of trained professionals may hamper the global clinical trial supplies market in the long run. also, lack of infrastructure negatively impacts market growth. the current industry trends, such as a surge in focus on determining toxicity level in the early stages of drug discovery, globalization, and rise in the number of clinical trials, are expected to provide market players with new market opportunities.
The clinical trial supplies market is vast, with many local and global players. the key leaders follow different strategies to augment their market position, such as mergers, contracts, extending product portfolio, expansions, acquisitions, and product innovations to enhance their market share at the global level. The known players included in the report are PAREXEL International Corporation, KLIFO A/S, Movianto GmbH, Biocair International Ltd., Almac Group Ltd, Patheon Inc., Thermo Fischer Scientific, PCI Services, Sharp Packaging Services, and Catalent Pharma Solutions.
In this research report, the clinical trial supplies market is segmented by phase, services, therapeutic area, and region.
Analysis by Phases:
By Phases, the report is categorized into phase I, phase II, phase III, phase IV, and BA/BE studies. Phase III dominates the phases segment with over 20% share in 2020. Phase III trials are the most costly, time-consuming, and difficult to design and run. Moreover, it necessitates thousands of people to execute experiments. These experiments go for a more extended period, requiring more supplies and services in several pharma companies and contract research organizations (CROs), thus contributing to the high demand for clinical trial supplies in the forecast period.
Analysis by Services:
By services, the report is categorized into manufacturing, packaging, labeling, and blinding, comparator sourcing, logistics, distribution, storage, and retention, and solutions. Logistics services dominate the product segment with over 60% share in 2020. It is due to the globalization of clinical trials and the increasing number of clinical trials involving temperature-sensitive products. Moreover, growing awareness regarding the importance of clinical trial logistics and end-to-end solutions for respecting the desired study timelines contributes to the growth of the logistics segment in the forecast period.
Analysis by Therapeutic Area:
By therapeutic area, the report is categorized oncology, neurological and mental disorders, infectious and immune system diseases, digestive system diseases, blood disorders, and other therapeutic areas. Oncology areas are estimated to show considerable growth in the forecast period. It is due to the increasing demand for technologically advanced cell-based therapies. Moreover, the adoption of advanced instruments and consumables in pharmaceutical and biotechnology companies for cancer research and experiments drives the demand from the oncology segment in the forecast period.
Analysis by Region:
In the regional outlook of the global clinical trial supplies market, the North America region dominates with a market share of 30% in 2020. It is due to the presence of well-established CROs and the growing investments in R&D by pharmaceutical and biopharmaceutical in the U.S. that are driving the North America region. Moreover, the increasing occurrence of chronic diseases and rise in the number of life sciences researches contribute to the high growth of the clinical trial supplies market across North America.
Market Segmentation covered in the Report:
By Clinical Phase
- Phase I
- Phase II
- Phase III
- Other
- Manufacturing
- Packaging, Labeling, and Blinding
- Comparator Sourcing
- Logistics
- Distribution, Storage, and Retention
- Solutions
- Oncology
- Neurological and Mental Disorders
- Infectious and Immune System Diseases
- Digestive System Diseases
- Blood Disorders
- Other Therapeutic Areas
- North America
- Europe
- The Asia Pacific
- Latin America
- The Middle East and Africa
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . CLINICAL TRIAL SUPPLIES – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 By Clinical Phase
3.7.2 By Service
3.7.3 By Therapeutic Area
3.7.4 By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL CLINICAL TRIAL SUPPLIES MARKET ANALYSIS BY CLINICAL PHASE
6.1 Overview by Clinical Phase
6.2 Historical and Forecast Data
6.3 Analysis by Clinical Phase
6.4 Phase I Market by Regions
6.5 Phase II Market by Regions
6.6 Phase III Market by Regions
6.7 Other Market by Regions
7 . GLOBAL CLINICAL TRIAL SUPPLIES MARKET ANALYSIS BY SERVICE
7.1 Overview by Service
7.2 Historical and Forecast Data
7.3 Analysis by Service
7.4 Manufacturing Market by Regions
7.5 Packaging, Labeling, and Blinding Market by Regions
7.6 Comparator Sourcing Market by Regions
7.7 Logistics Market by Regions
7.8 Distribution, Storage, and Retention Market by Regions
7.9 Solutions Market by Regions
8 . GLOBAL CLINICAL TRIAL SUPPLIES MARKET ANALYSIS BY THERAPEUTIC AREA
8.1 Overview by Therapeutic Area
8.2 Historical and Forecast Data
8.3 Analysis by Therapeutic Area
8.4 Oncology Market by Regions
8.5 Neurological and Mental Disorders Market by Regions
8.6 Infectious and Immune System Diseases Market by Regions
8.7 Digestive System Diseases Market by Regions
8.8 Blood Disorders Market by Regions
8.9 Other Therapeutic Areas Market by Regions
9 . GLOBAL CLINICAL TRIAL SUPPLIES MARKET ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook
9.2. Introduction
9.3. North America
9.3.1. Overview, Historic and Forecast Data
9.3.2. North America By Segment
9.3.3. North America By Country
9.3.4. United State
9.3.5. Canada
9.3.6. Mexico
9.4. Europe
9.4.1. Overview, Historic and Forecast Data
9.4.2. Europe by Segment
9.4.3. Europe by Country
9.4.4. United Kingdom
9.4.5. France
9.4.6. Germany
9.4.7. Italy
9.4.8. Russia
9.4.9. Rest Of Europe
9.5. Asia Pacific
9.5.1. Overview, Historic and Forecast Data
9.5.2. Asia Pacific by Segment
9.5.3. Asia Pacific by Country
9.5.4. China
9.5.5. India
9.5.6. Japan
9.5.7. South Korea
9.5.8. Australia
9.5.9. Rest Of Asia Pacific
9.6. Latin America
9.6.1. Overview, Historic and Forecast Data
9.6.2. Latin America by Segment
9.6.3. Latin America by Country
9.6.4. Brazil
9.6.5. Argentina
9.6.6. Peru
9.6.7. Chile
9.6.8. Rest of Latin America
9.7. Middle East & Africa
9.7.1. Overview, Historic and Forecast Data
9.7.2. Middle East & Africa by Segment
9.7.3. Middle East & Africa by Country
9.7.4. Saudi Arabia
9.7.5. UAE
9.7.6. Israel
9.7.7. South Africa
9.7.8. Rest Of Middle East And Africa
10 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIAL SUPPLIES COMPANIES
10.1. Clinical Trial Supplies Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11 . COMPANY PROFILES OF CLINICAL TRIAL SUPPLIES INDUSTRY
11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. PAREXEL International Corporation
11.3.1. Company Overview
11.3.2. Financials
11.3.3. Products
11.3.4. Recent Developments
11.4. KLIFO A/S
11.4.1. Company Overview
11.4.2. Financials
11.4.3. Products
11.4.4. Recent Developments
11.5. Movianto GmbH
11.5.1. Company Overview
11.5.2. Financials
11.5.3. Products
11.5.4. Recent Developments
11.6. Biocair International Ltd.
11.6.1. Company Overview
11.6.2. Financials
11.6.3. Products
11.6.4. Recent Developments
11.7. Almac Group Ltd, Patheon Inc.
11.7.1. Company Overview
11.7.2. Financials
11.7.3. Products
11.7.4. Recent Developments
11.8. Thermo Fischer Scientific
11.8.1. Company Overview
11.8.2. Financials
11.8.3. Products
11.8.4. Recent Developments
11.9. PCI Services
11.9.1. Company Overview
11.9.2. Financials
11.9.3. Products
11.9.4. Recent Developments
11.10. Sharp Packaging Services
11.10.1. Company Overview
11.10.2. Financials
11.10.3. Products
11.10.4. Recent Developments
11.11. Catalent Pharma Solutions
11.11.1. Company Overview
11.11.2. Financials
11.11.3. Products
11.11.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Clinical Phase (USD MN)
- Phase I Market by Geography (USD MN)
- Phase II Market by Geography (USD MN)
- Phase III Market by Geography (USD MN)
- Other Market by Geography (USD MN)
- Analysis Market by Service (USD MN)
- Manufacturing Market by Geography (USD MN)
- Packaging, Labeling, and Blinding Market by Geography (USD MN)
- Comparator Sourcing Market by Geography (USD MN)
- Logistics Market by Geography (USD MN)
- Distribution, Storage, and Retention Market by Geography (USD MN)
- Solutions Market by Geography (USD MN)
- Analysis by Therapeutic Area (USD MN)
- Oncology Market by Geography (USD MN)
- Neurological and Mental Disorders Market by Geography (USD MN)
- Infectious and Immune System Diseases Market by Geography (USD MN)
- Digestive System Diseases Market by Geography (USD MN)
- Blood Disorders Market by Geography (USD MN)
- Other Therapeutic Areas Market by Geography (USD MN)
- Global Clinical Trial Supplies Market by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
LIST OF FIGURES
- Research Scope of Clinical Trial Supplies Report
- Market Research Process
- Market Research Methodology
- Global Clinical Trial Supplies Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Clinical Phase
- Market Attractiveness Analysis by Service
- Market Attractiveness Analysis by Therapeutic Area
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Clinical Phase (USD MN)
- Phase I Market by Geography (USD MN)
- Phase II Market by Geography (USD MN)
- Phase III Market by Geography (USD MN)
- Other Market by Geography (USD MN)
- Global Market Analysis by Service (USD MN)
- Manufacturing Market by Geography (USD MN)
- Packaging, Labeling, and Blinding Market by Geography (USD MN)
- Comparator Sourcing Market by Geography (USD MN)
- Logistics Market by Geography (USD MN)
- Distribution, Storage, and Retention Market by Geography (USD MN)
- Solutions Market by Geography (USD MN)
- Global Market Analysis by Therapeutic Area (USD MN)
- Oncology Market by Geography (USD MN)
- Neurological and Mental Disorders Market by Geography (USD MN)
- Infectious and Immune System Diseases Market by Geography (USD MN)
- Digestive System Diseases Market by Geography (USD MN)
- Blood Disorders Market by Geography (USD MN)
- Other Therapeutic Areas Market by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Company Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Related Categories
Pharmaceuticals
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments